|Articles|May 20, 2020
ERT Announces Virtual Visit Capabilities
Advertisement
ERT has announced a Virtual Visit solution that enables the continuation of clinical trials during and after current global stay-at-home mandates due to the COVID-19 outbreak. ERT’s Virtual Visit solution enables at-home consultations between patients and investigative site personnel via a dedicated, secure app or web interface.
For more information, click
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Breaking the Efficacy Ceiling in IBD and Beyond
2
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
3
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
4
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
5